The IJTLD (ISSN:1815-7920) provides a free-to-publish journal for authors (mainly in LMICs), who lack open access funding and conduct research on respiratory health.
The Journal primarily focuses on infectious diseases, including TB and non-tuberculous mycobacterial (NTM) infections, alongside the role of risk factors and comorbidities, with the aim of improving clinical care, policy and practise.
Individuals and Institutes can subscribe to the IJTLD online, simply e-mail us at subscription@theunion.org
Information for Authors
Abstract and indexing services include: Medline, PubMed, Scopus, EMBASE, Web of Science, SciSearch®, Medical Documentation Service®, ISI Alerting Services, Current Contents®/Clinical Medicine, the Science Citation Index®, the SIIC databases, CLOCKSS and LOCKSS.
Other Information
- Frequency: monthly
- Permission requests: contact IJTLD Editorial Office.
There are no fees for articles that meet our recommended page lengths, but there are fees for additional pages or supplementary data - see Journal Publication Charges
IJTLD Open as an open access alternative to the IJTLD. The Journal focuses on infectious diseases, including TB and non-tuberculous mycobacteria (NTM), alongside the role of risk factors and comorbidities.
IJTLD Open includes a broader range of article types than the traditional IJTLD, including: Editorials, Meeting reports; Original Articles (including methodology papers, qualitative research and operational research), State of the Art Reviews; Guidelines/Consensus documents; Systematic Reviews and Meta-Analysis; Viewpoints; Minireviews, Letters; Study Protocols; Case reports; Case series and Correspondence.
We have launched IJTLD CRD for open access coverage of chronic respiratory disease in low- and middle-income countries.
IJTLD CRD coverage includes: post TB lung disease (PTLD), asthma, COPD, impact of air pollution, lung damage in smokers, interstitial lung disease, bronchiectasis, long COVID, sleep apnoea, occupational lung disease and interventional pulmonology.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions.
The latest peer-reviewed articles on TB and HIV; respiratory diseases such as asthma and COPD; and the hazards of tobacco and air pollution. Recent coverage has expended to include COVID-19 and the interplay between TB-COVID-19 and other co-morbidities.
Individuals and institutes can subscribe to the IJTLD online – see our Subscription information or e-mail us at subscription@theunion.org for details.
IJTLD Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and publishing them in full on our website, prior to their publication in the Journal. Read fast-track articles:
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
A year in review – evaluating the launch of IJTLD OPEN
An Editorial in a forthcoming issue of IJTLD OPEN describes how open access has driven a dramatic increase in visibility.
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea
An article in a forthcoming issue of PHA assesses the reasons for loss-to-follow-up in patients being treated for disease resistant TB.
Other versions of the journal
The IJTLD has been published in several languages, and publishes the Union World Conference abstract book each year.
Contact
For all IJTLD enquiries, please contact the IJTLD Editorial Office.